Roche Statistics
Share Statistics
Roche has 6.42B
shares outstanding. The number of shares has increased by -0.86%
in one year.
| Shares Outstanding | 6.42B |
| Shares Change (YoY) | -0.86% |
| Shares Change (QoQ) | -0.06% |
| Owned by Institutions (%) | 0.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 54,090 |
| FTD / Avg. Volume | 1.54% |
Short Selling Information
The latest short interest is 4.3M, so 0% of the outstanding
shares have been sold short.
| Short Interest | 4.3M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.01 |
Valuation Ratios
The PE ratio is 24.45 and the forward
PE ratio is null.
Roche's PEG ratio is
-0.87.
| PE Ratio | 24.45 |
| Forward PE | n/a |
| PS Ratio | 3.24 |
| Forward PS | n/a |
| PB Ratio | 6.37 |
| P/FCF Ratio | 13.42 |
| PEG Ratio | -0.87 |
Financial Ratio HistoryEnterprise Valuation
Roche has an Enterprise Value (EV) of 54.68B.
| EV / Sales | 0.88 |
| EV / EBITDA | 3.29 |
| EV / EBIT | 2.72 |
| EV / FCF | 3.62 |
Financial Position
The company has a current ratio of 1.48,
with a Debt / Equity ratio of 1.14.
| Current Ratio | 1.48 |
| Quick Ratio | 1.2 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | 2.41 |
| Interest Coverage | 9.56 |
Financial Efficiency
Return on Equity is 26.06% and Return on Invested Capital is 13.22%.
| Return on Equity | 26.06% |
| Return on Assets | 8.13% |
| Return on Invested Capital | 13.22% |
| Revenue Per Employee | $604,315.78 |
| Profits Per Employee | $80,165.43 |
| Employee Count | 103,249 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 2.14 |
Taxes
| Income Tax | 2.61B |
| Effective Tax Rate | 22.1% |
Stock Price Statistics
The stock price has increased by 23.65% in the
last 52 weeks. The beta is 0.17, so Roche's
price volatility has been higher than the market average.
| Beta | 0.17 |
| 52-Week Price Change | 23.65% |
| 50-Day Moving Average | 40.77 |
| 200-Day Moving Average | 39.14 |
| Relative Strength Index (RSI) | 40.83 |
| Average Volume (20 Days) | 3,514,785 |
Income Statement
In the last 12 months, Roche had revenue of 62.4B
and earned 8.28B
in profits. Earnings per share was 1.3.
| Revenue | 62.4B |
| Gross Profit | 46.11B |
| Operating Income | 13.42B |
| Net Income | 8.28B |
| EBITDA | 16.62B |
| EBIT | 13.2B |
| Earnings Per Share (EPS) | 1.3 |
Full Income StatementBalance Sheet
The company has 6.97B in cash and 36.35B in
debt, giving a net cash position of -29.38B.
| Cash & Cash Equivalents | 6.97B |
| Total Debt | 36.35B |
| Net Cash | -29.38B |
| Retained Earnings | 43.84B |
| Total Assets | 101.8B |
| Working Capital | 13.01B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 20.09B
and capital expenditures -5.01B, giving a free cash flow of 15.09B.
| Operating Cash Flow | 20.09B |
| Capital Expenditures | -5.01B |
| Free Cash Flow | 15.09B |
| FCF Per Share | 18.88 |
Full Cash Flow StatementMargins
Gross margin is 73.9%, with operating and profit margins of 21.5% and 13.27%.
| Gross Margin | 73.9% |
| Operating Margin | 21.5% |
| Pretax Margin | 18.9% |
| Profit Margin | 13.27% |
| EBITDA Margin | 26.64% |
| EBIT Margin | 21.5% |
| FCF Margin | 24.18% |
